Artificial Intelligence Technologies for COVID-19 De Novo Drug Design
The recent covid crisis has provided important lessons for academia and industry regarding digital reorganization. Among the fascinating lessons from these times is the huge potential of data analytics and artificial intelligence. The crisis exponentially accelerated the adoption of analytics and ar...
Main Authors: | Giuseppe Floresta, Chiara Zagni, Davide Gentile, Vincenzo Patamia, Antonio Rescifina |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/6/3261 |
Similar Items
-
From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes
by: Giuseppe Floresta, et al.
Published: (2021-12-01) -
Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs
by: Georgia Dorahy, et al.
Published: (2023-01-01) -
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
by: Ri Han, et al.
Published: (2023-09-01) -
De novo drug design through artificial intelligence: an introduction
by: Davide Crucitti, et al.
Published: (2024-01-01) -
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study
by: Vincenzo Patamia, et al.
Published: (2023-01-01)